AAAlawi Aqel Al-Attas

Alawi Aqel Al-Attas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alawi Aqel Al-Attas has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Saleh K. Swailem

    Department of Neurology, King Fahad Specialist Hospital, Burydah, Saudi Arabia

    3 shared publications
  • Riyam F. Al Anazi

    Department of Pediatric Neurology, Al Yamama Hospital, Riyadh, Kingdom of Saudi Arabia

    2 shared publications
  • Abdulrahman G. Malhan

    Department of Internal Medicine, King Abdullah Hospital, Bisha, Saudi Arabia

    1 shared publication
  • Abdulrahman Nazer

    Department of Neurosurgery, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

    1 shared publication
  • Abdulrahman Yousef Aldayel

    Department of Neurology, Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia

    1 shared publication
  • Abeer Alshaikh

    Department of Neurology, Division of Epilepsy, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

    1 shared publication

Latest Publications

  • Open Access

    The Promise Between Ancient Wisdom and Modern Science for Nigella sativa as a Multimodal Agent in Healthspan Extension: A Narrative Review

    by Alawi A Al-Attas

    Longevity medicine increasingly focuses on extending healthspan rather than lifespan alone, and Nigella sativa (black seed), with its long history of traditional use, along with thymoquinone (TQ), its principal bioactive compound, has drawn growing interest for its effects on several pathways implicated in aging. To summarize the evidence for N. sativa as a potential healthspan-promoting agent, we conducted a narrative review of the peer-reviewed literature from PubMed, Scopus, and Web of Science, together with classical Islamic medical texts and authenticated Prophetic narrations, considering in vitro studies, animal studies, and human randomized controlled trials, with a focus on aging-related mechanisms, human evidence, Islamic medical tradition, and remaining research gaps. Case reports and case series were excluded. TQ shows antioxidant, anti-inflammatory, metabolic, neuroprotective, and cellular effects relevant to several hallmarks of aging, and human studies show modest improvements in cardiometabolic risk factors, inflammatory markers, oxidative stress, and some cognitive measures. Overall, N. sativa is a promising multimodal candidate for healthspan research, but evidence that it extends human healthspan is not yet established, and longer trials using standardized preparations and aging-specific outcomes are needed.

  • Open Access

    Sick Sinus Syndrome and Cerebral Venous Thrombosis: A Connection or Coincidence? A Case Report and Literature Review

    by Alawi A. Al-Attas, Njood A. Alhrkan, Muteb A. Alwatid, Saifullah M. Zaman, Mohammed F. Salawaty, Nouf A. Mansour

    It has been hypothesized that increased intracranial pressure (ICP) may cause sick sinus syndrome (SSS) due to its effect on vagal discharge to the heart, resulting in disruption to the sinus cycle, despite age-related degeneration of the sinoatrial node being the most common intrinsic factor leading to sinus node dysfunction. In this case report, a 47-year-old man with unknown medical conditions presented to the emergency department at King Saud Medical City with a four-day history of headache, confusion, and chest pain. He also reported dizziness and lightheaded. Extensive cerebral venous thrombosis (CVT) and SSS were identified. We investigated the SSS etiology and its relation to CVT, concluding that SSS was caused by elevated ICP secondary to CVT.

  • Open Access

    Safety and effectiveness of vagus nerve stimulation in patients with drug-resistant epilepsy: a single center experience

    by Ebtehal Alwazna, Jamal Abdullah, Hanin Alsini, Marahib Alshahrani, Wafa Aldhafeeri, Alawi Al-Attas, Abeer Alshaikh, Mashael Alanazi, Hamoud Alsahli, Mohammed Alshahrani, et al.

    Background: Drug-resistant epilepsy (DRE) exerts substantial clinical, humanistic and economic burdens on patients, their families and the healthcare system. Vagus nerve stimulation (VNS) has been extensively tested in clinical trial settings to decrease the frequency of seizures in patients with DRE who are not candidates for surgery; the results indicate promising efficacy and a well-tolerated safety profile. However, real-world evidence is still lacking. This retrospective study evaluated the safety and efficacy of VNS in patients with DRE. Methods: The current study was a retrospective chart review of the medical records of children and adults with DRE treated with VNS between December 2006 and November 2022. The primary outcome of the present study was the percentage of patients who experienced a reduction in seizure frequency of more than 50% compared with the frequency at baseline (the period before VNS device insertion). Results: A total of 103 patients were included. The percentage of patients who achieved a reduction of more than 50% in seizure frequency was 23% at six months, 36% at 12 months, 65% at 18 months, and 72% at 24 months. Similarly, the percentage of patients with complete resolution of interictal epileptiform discharges (IEDs) increased from 30% at six months to 60% after 24 months. The overall Quality of Life in Epilepsy (QOLIE-31) score at the end of follow-up was 39.46 ± 13.68 points. Two patients (1.9%) reported experiencing side effects at the end of follow-up. Conclusions: VNS implementation led to a significant reduction in the seizure frequency and resolution of IEDs, with a well-tolerated safety profile. The findings highlight the potential role of VNS in managing DRE and warrant its consideration for treating patients with DRE.


  • Open Access

    Rituximab for Leucine-Rich Glioma-Inactivated 1 (LGI1) Antibody-Related Super-refractory Status Epilepticus: A Case Report and Literature Review

    by Alawi A. Al-Attas, Samar E. Eshetaiwe, Mesdah A. Alnahdi, Hoda M. Nassar, Ahmed H. Althobaiti

    Leucine-rich glioma-inactivated 1 (LGI1) encephalitis is a form of autoimmune encephalitis (AE) that presents with memory loss, faciobrachial dystonic seizures (FBDSs), disorientation, psychiatric symptoms, and hyponatremia. Diagnosis is based on clinical presentation, magnetic resonance imaging (MRI), serum or cerebrospinal fluid (CSF) antibody testing, and electroencephalography (EEG) findings. Most available studies on its clinical features and treatment are limited to case reports and series, highlighting the need for a comprehensive understanding and standardized treatment approach. Herein, we report a 61-year-old Saudi retiree with cognitive decline, recurrent right FBDS, generalized tonic-clonic seizures, and persistent hyponatremia who showed a significant improvement after rituximab therapy.


  • Open Access

    Epileptic Nocturnal Wanderings in a Young Female: A Rare Case Report and Review of the Literature

    by Attas A. Al-Attas, Maryam A. Al-Attas, Saleh K. Swailem

    Sleep-related hyperkinetic seizures are a frequent symptom of frontal lobe epilepsy that occurs at night. Although temporal lobe-originating sleep-related seizures have been documented, they often lack hyperkinetic activity. Furthermore, episodic nocturnal wandering is rarely observed and is believed to represent an unusual form of nocturnal epilepsy that responds to anti-seizure medications. In this report, we present a case of a 14-year-old right-handed girl with recurrent sleepwalking and wandering. Interictal electroencephalography revealed an epileptogenic focus in the left temporal lobe and intermittent slow-wave activity originating from that region. During her nighttime wanderings, the patient exhibited unusually violent and nonviolent conduct, putting herself at risk of minor or serious injuries.


  • Open Access

    The Prevalence of Depression in Patients With Epilepsy in the Kingdom of Saudi Arabia

    by Saleh K. Swailem, Fawziah A Bamogaddam, Alawi A Al-Attas

    Objective Among patients with epilepsy (PWE), the prevalence of depression ranges from 30% to 50%, with a 5-25% prevalence of suicide. Depression and epilepsy affect daily tasks such as driving, employment, and physical activity. Depression is the most common comorbidity among patients with epilepsy. Because both conditions involve pathophysiological changes, treating mood disorders helps treat epilepsy and vice versa. Studies about epilepsy and depression in Saudi Arabia are scarce, and no study has been conducted on this topic at King Fahad Medical City (KFMC); hence, we aimed to determine the prevalence of depression among PWE who were followed up at KFMC. Methods This retrospective hospital-based study was conducted at KFMC in Riyadh, Saudi Arabia. This investigation spanned a period of 10 years, from 2008 to 2018. The study included patients with PWE who were diagnosed with depression. Results According to a study of individuals aged 18 to 69, 73.7% of patients had been diagnosed with chronic depression (i.e., for more than a year); most of these patients had completed elementary school. Higher rates of depression were also observed among elementary school pupils, divorced women, and non-Riyadh residents. A correlation was observed between the severity of depression based on the Patient’s Health Questionnaire( PHQ-9) score, which was used to screen for depression and diabetes mellitus (DM), the number of antidepressant medications (ADM) used, the duration of antidepressant use, suicidal ideation or attempts, and the duration of depression. Epilepsy was most prevalent in the temporal lobe, accounting for 22.6% of all cases, and it was managed in 78.2% of the patients. The duration of epilepsy was significantly associated with the severity of depression.


  • Open Access

    Knowledge, attitudes and practices of the Saudi population toward people with epilepsy: narrow or wide?

    by Alawi A. Al-Attas, Omar K. Alshehri, Abdulrahman G. Malhan, Hani M. Alabdaly, Osamah K. Alfentokh, Amen A. Bawazir

    Background: Although epilepsy has been acknowledged as an illness since ancient time, the public attitude toward epilepsy has not changed drastically due to the lack of appropriate information. This study aims to determine the public perceptions of epilepsy in five main regions of Saudi Arabia. Methods: In this cross-sectional questionnaire-based study, Saudi citizens living in the major cities of the five main regions of the Kingdom of Saudi Arabia (the central, eastern, western, northern, and southern regions) completed the survey that included 27 questions about epilepsy awareness. Results: A total of 7118 individuals from five regions participated in the survey: 6749 (94.8%) of respondents were Saudi, and 369 (5.2%) were non-Saudi. Of the 7118 respondents, 6897 respondents (96.9%) did not have epilepsy, and 3378 respondents (47.5%) stated that they had never witnessed an epileptic episode. In addition, 3749 (52.7%) respondents incorrectly attributed epilepsy to non-neurologic conditions, and 4865 (68.3%) respondents had an overall negative attitude toward people with epilepsy (PWE). They expressed objections to their child associating with PWE (2002; 28.1%) or their close relatives marrying PWE (3192; 44.8%), some believed that PWE are inferior (402; 5.6%), refused to hire a PWE (1126; 15.8%), and would feel discomfort around PWE (724; 10.3%). In addition, 2025 individuals (28.4%) believed that the health of PWE deteriorates over time; 1485 individuals (20.9%) believed that PWE get sick more often than others; 181 individuals (2.5%) believed that epilepsy could be transmitted; and 568 individuals (8.0%) believed that epilepsy could progress to malignant disease. Conclusions: In Saudi Arabia, there is a substantial need for increasing the awareness and improving education on epilepsy in order to reduce stigma and increase the understanding of epilepsy. Such efforts could help improve the lives of people afflicted with the disease and ultimately contribute to better health outcomes for the entire community.


  • Open Access

    Clinical importance of peri-ictal water drinking

    by Alawi A. Al-Attas

    Background: Peri-ictal water drinking is drinking water within a short period or during a seizure. This behavior can be experienced in childhood and adulthood and commonly affects adults suffering from temporal lobe epilepsy. Peri-ictal water drinking has clinical importance for lateralizing signs in the non-dominant hemisphere. It has been found in up to 7–15% of patients with focal epilepsy. Case presentation: This case study involved a 44-year-old right-handed female referred tour center as a case of drug-resistant epilepsy for presurgical evaluation. After evaluation in the Epilepsy Monitoring Unit, the patient was considered a candidate for right temporal lobectomy. The patient exhibited good outcome post-temporal lobectomy. Conclusions: This case highlights the previously observed association between peri-ictal water drinking and the non-dominant hemisphere in patients with epilepsy. Clinicians must not overlook this automatic behavior that both patients and physicians usually underestimate because drinking water is a normal phenomenon.

  • Sudden unexpected death in epilepsy: What Saudi people with epilepsy want to know—A cross‐sectional study

    by Talal K. Aljumah, Alawi A. Al‐Attas, Ahmed A. Alqahtani, Emad M. Masuadi, Ahmed S. Aldahi, Mohammed A. Alshammari, Alaa T. Heji, Ali Alanazi

    Objective: Sudden unexpected death in epilepsy (SUDEP) is a significant cause of mortality in people with epilepsy (PWE), with an incidence of 1 per 1000 members of the population. In Saudi Arabia, no data are available that inform local clinical practitioners about the attitudes of PWE regarding SUDEP. The aim of this study was to investigate the perspectives of Saudi PWE toward SUDEP and to assess their knowledge of SUDEP.Methods: A cross‐sectional questionnaire‐based study was conducted at the neurology clinics of King Abdul‐Aziz Medical City, Riyadh and Prince Sultan Military Medical City, Riyadh.Results: Of the 377 patients who met the inclusion criteria, 325 completed the questionnaire. The mean age of the respondents was 32.9 ± 12.6 years. Of the study subjects, 50.5% were male. Only 41 patients (12.6%) had heard about SUDEP. Most patients (94.5%) wanted to know about SUDEP, of whom 313 (96.3%) wanted to receive this information from a neurologist. A total of 148 patients (45.5%) thought that the appropriate time to receive information about SUDEP was after the second visit, whereas only 75 (23.1%) wanted to learn about SUDEP during the first visit. However, 69 patients (21.2%) thought that the appropriate time to be informed about SUDEP was when seizure control had become more difficult. Almost half (172, 52.9%) of the patients thought that SUDEP could be prevented.Significance: Our findings suggest that most Saudi PWE do not know about SUDEP and want to be counseled about their risk of SUDEP by their physicians. Therefore, education of Saudi PWE about SUDEP must be improved.


  • Open Access

    Weighing Successes and Challenges in the Establishment of Additional Epilepsy Monitoring Units at the Saudi Arabian Kingdom's Capital City

    by Alawi A Al-Attas

    Epilepsy has a prevalence rate of 6.54 per 1,000 people in Saudi Arabia, making it a prevalent chronic condition. Drug-resistant epilepsy (DRE) is thought to affect one-third of patients; in these circumstances, a complete presurgical examination in the epilepsy monitoring unit (EMU) is necessary. Unfortunately, to accommodate the growing number of referrals, the units' availability and number must be reviewed.